Paion Pharma GmbH
3 products tracked · names used in filings: Paion Pharma GmbH, PAION Pharma GmbH
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Byfavo remimazolam | Authorised | 2021-03-26 |
| 🇪🇺 | Giapreza angiotensin II | Authorised | 2019-08-23 |
| 🇪🇺 | Xerava eravacycline | Authorised | 2018-09-20 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.